UBS AM
RXRX icon

UBS AM’s Recursion Pharmaceuticals RXRX Stock Holding History

UBS AM’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4M Sell
4,023,398
-51,821
-1% -$200K ﹤0.01% 1096
2025
Q4 		$16.7M Sell
4,075,219
-121,759
-3% -$603K ﹤0.01% 912
2025
Q3 		$20.5M Sell
4,196,978
-418,538
-9% -$2.2M ﹤0.01% 816
2025
Q2 		$23.4M Sell
4,615,516
-1,793,008
-28% -$8.81M ﹤0.01% 993
2025
Q1 		$33.9M Buy
6,408,524
+4,149,346
+184% +$30.2M 0.01% 772
2024
Q4 		$15.3M Buy
2,259,178
+118,428
+6% +$796K ﹤0.01% 1062
2024
Q3 		$14.1M Buy
2,140,750
+43,078
+2% +$309K ﹤0.01% 1084
2024
Q2 		$15.7M Buy
2,097,672
+1,891,903
+919% +$16.5M ﹤0.01% 960
2024
Q1 		$2.05M Sell
205,769
-21,104
-9% -$235K ﹤0.01% 1684
2023
Q4 		$2.24M Buy
226,873
+15,297
+7% +$109K ﹤0.01% 1640
2023
Q3 		$1.62M Buy
211,576
+96,298
+84% +$961K ﹤0.01% 1727
2023
Q2 		$769K Hold
115,278
– – ﹤0.01% 2122
2023
Q1 		$769K Buy
115,278
+8,347
+8% +$66.2K ﹤0.01% 2122
2022
Q4 		$824K Buy
106,931
+30,052
+39% +$295K ﹤0.01% 1949
2022
Q3 		$818K Buy
76,879
+25,426
+49% +$258K ﹤0.01% 2086
2022
Q2 		$419K Buy
51,453
+3,259
+7% +$21.8K ﹤0.01% 2364
2022
Q1 		$345K Buy
48,194
+12,741
+36% +$135K ﹤0.01% 2563
2021
Q4 		$607K Buy
+35,453
New +$667K ﹤0.01% 2474

Other funds holding RXRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return